|
G |
Ccne1 |
cyclin E1 |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of CCNE1 mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
affects binding |
EXP |
Nitrofurazone binds to GSK3B protein |
CTD |
PMID:18222664 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Nitrofurazone co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Nitrofurazone results in increased expression of IL1B mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Nitrofurazone co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
Nitrofurazone inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of JUN mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression |
EXP |
Nitrofurazone results in decreased expression of LHB protein |
CTD |
PMID:11548123 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mir128-1 |
microRNA 128-1 |
increases expression |
EXP |
Nitrofurazone results in increased expression of MIR128-1 mRNA |
CTD |
PMID:32418910 |
|
NCBI chr13:39,699,449...39,699,530
Ensembl chr13:39,699,449...39,699,530
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression multiple interactions |
EXP |
Nitrofurazone results in increased expression of MYC mRNA Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of MYC mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[Nitrofurazone co-treated with POR protein co-treated with Copper] results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine; Nitrofurazone inhibits the reaction [POR protein results in increased metabolism of Misonidazole] |
CTD |
PMID:6802140 PMID:15488632 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Prl |
prolactin |
decreases expression |
EXP |
Nitrofurazone results in decreased expression of PRL protein |
CTD |
PMID:11548123 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Tgfa |
transforming growth factor alpha |
increases expression multiple interactions |
EXP |
Nitrofurazone results in increased expression of TGFA mRNA Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TGFA mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TNF mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases mutagenesis |
ISO |
Nitrofurazone results in increased mutagenesis of TP53 gene |
CTD |
PMID:15488632 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased expression of H2AX protein |
CTD |
PMID:25130544 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases oxidation |
ISO |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased oxidation of PRDX3 protein |
CTD |
PMID:21195754 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
multiple interactions |
ISO |
[Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein |
CTD |
PMID:20954859 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Txn2 |
thioredoxin 2 |
increases oxidation multiple interactions |
ISO |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased oxidation of TXN2 protein [3-aminopyridine-2-carboxaldehyde thiosemicarbazone binds to Iron] which results in increased oxidation of TXN2 protein |
CTD |
PMID:21195754 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|